Evidence map›Paper›PMID 39158686›Full record

ReviewUrologie (Heidelberg, Germany)2024

[Perineal prostate biopsy].

Paulo Leonardo Pfitzinger, Darjusch Andreas Askari, Troya Ivanova, Marina Hoffmann, Iulia Blajan, Michael Atzler, Leo Federico Stadelmeier, Maria Apfelbeck, Michael Chaloupka, Philipp Kazmierczak and 2 more

Erratum issuedAbstract readReviewEnglish Abstract
PubMed Publisher
In one paragraph

Review in Urologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Erratum issued
    2024
5 · Who and what money

Authors and funding

12 authors.

Paulo Leonardo PfitzingerUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland. paulo.pfitzinger@med.uni-muenchen.de.
Darjusch Andreas AskariUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Troya IvanovaUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Marina HoffmannUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Iulia BlajanUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Michael AtzlerUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Leo Federico StadelmeierUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Maria ApfelbeckUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Michael ChaloupkaUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Philipp KazmierczakUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Christian StiefUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
Benazir EnzingerUrologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prostate biopsy is an essential tool for diagnosing prostate cancer (PCa). While transrectal biopsy (TR-Bx) continues to be considered the gold standard in Germany, the European Association of Urology (EAU) guidelines increasingly recommend transperineal biopsy (TP-Bx) due to lower infection rates and higher tumor detection rates. This article provides an overview of the history and development of the perineal biopsy, compares TR-Bx and TP-Bx and discusses the need for antibiotic prophylaxis before TP-Bx. Current studies have shown that TP-Bx can be performed without antibiotic prophylaxis and new techniques such as robotic-assisted and vector biopsy show very precise results. The establishment of TP-Bx is being promoted by extrabudgetary funding and technological advancements, with the choice of biopsy method remaining an individual decision jointly made in dialogue with the patient.

Indexed as

PerineumProstateProstatic NeoplasmsAntibiotic ProphylaxisBiopsyHumansMaleAntibiotic prophylaxisBiopsy methodLocal anesthesiaProstatic neoplasmsTissue sample

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.